Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
63 Results for "
TGF-beta1
" in MedChemExpress (MCE) Product Catalog:
Products (63)
63 Results for "TGF-beta1" in MCE Product Catalog:
182
182 Publications Verification
Cat. No.: HY-P7118
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Human
Source:
CHO
76
76 Cited Publications
Cat. No.: HY-P7117
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Rat
Mouse
Source:
HEK293
61
61 Cited Publications
Cat. No.: HY-P70543
Purity: ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Human
Source:
HEK293
34
34 Cited Publications
Cat. No.: HY-P70648
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Rat
Mouse
Source:
HEK293
7
7 Cited Publications
Cat. No.: HY-P78168
Purity: ≥ 90%, as determined by Bis-Tris PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Human
Source:
HEK293
5
3
3 Cited Publications
Synonyms: Antibiotic A 15104 Y; PClP
Target:
Research Areas:
Pentachloropseudilin (Antibiotic A 15104 Y; PClP) is a reversible and allosteric potent inhibitor of Myo1s (class 1 myosins) with IC50s range from 1 to 5 μM for mammalian class-1 myosins and greater than 90 μM for class-2 and class-5 myosins. Pentachloropseudilin is a potent inhibitor of transforming growth factor-β (TGF-β)-stimulated signaling, with an IC50 of 0.1 to 0.2 μM for TGF-β .
3
3 Cited Publications
Cat. No.: HY-P78360
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Mouse
Source:
HEK293
3
3 Cited Publications
Cat. No.: HY-P78668
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Human
Source:
HEK293
3
3 Cited Publications
Cat. No.: HY-P78213
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1; CAEND1; Transforming Growth Factor, beta 1; LAP; Diaphyseal Dysplasia 1, Progressive; Transforming Growth Factor beta 1; Transforming Growth Factor beta
Species:
Human
Source:
HEK293
2
1
BMS453 (BMS-189453), a synthetic retinoid, is a RARβ agonist and a RARα/RARγ antagonist. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ .
1
1 Cited Publications
Cat. No.: HY-P2294A
Target:
Research Areas:
1
1 Cited Publications
Cat. No.: HY-P70543G
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Human
Source:
CHO
1
1 Cited Publications
Cat. No.: HY-P73616
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P73615
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Rat
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P78214
Purity: ≥ 90%, as determined by Bis-Tris PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P70433
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P700227AF
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming Growth Factor beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-beta-1; CED; TGF-beta1; Transforming Growth Factor beta-1 Proprotein; IBDIMDE; Prepro-Transforming Growth Factor beta-1;
Species:
Rat
Mouse
Source:
E. coli
Cat. No.: HY-163536
CAS No.: 3043687-96-0
Target:
Research Areas:
TGF-β1/Smad3-IN-1 (Compound 5aa) is an inhibitor of the TGF-β1/Smad3 signaling pathway(IC50=1.07 μM). TGF-β1/Smad3-IN-1 possesses antifibrotic activity and oral potency [1].
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
